HDAC9 and immune system disorder: HDAC-mediated epigenetic modifications play a vital role in gene expression [16]; thus, the inhibition of HDAC induced by SCFA affects the progression of diseases that include metabolic diseases [17], immune diseases [18], and cancer [19].